Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.560EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.311EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.93EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.104EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.225EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.309EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.105EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.311NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.93NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.104NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.258.10NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.225NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
A.2.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AV.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.309NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.105NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.610NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.10 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.286NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.36.17NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.369NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.69NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.26NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.87NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21398.1Germany
FL.39.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.12NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GA.4.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HK.3.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.73 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.60 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.124.1 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GS.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.13.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GJ.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XYNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CH.1.1.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EG.5.2.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.45NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GP.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FL.4.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBQNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.6.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CR.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used